Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response

Table 1 UPS patient population characteristics.

Total patients included in the study	33
Total male	20 (61%)
Total female	13 (39%)
Average age	64 years (range 36–85 years)
Responders ( > = 90% PATE)	16
Partial responders (between 89% and 31% PATE)	10
Non-responders (< 30% PATE)	7
Total external baseline studies (conventional imaging)	10
Total PWI/DCE baseline studies (functional imaging)	23
Total PWI/DCE post-chemo studies	15
Total PWI/DCE post-radiation studies	30

PATE: Pathology-Assessed Treatment Effect; PWI/DCE: Perfusion-Weighted Imaging with Dynamic Contrast Enhancement.